Shinhiro Niai, a member of Suntory's founder family, will be the president, and Sina Gangshi will be the chairman. On December 12, it was announced that Suntory Holdings had finalized the personnel transfer, and Shinhiro Niai, a vice president from the founder family, will be promoted to the president, and the current president Sina Gangshi will be the chairman. It is expected that Nobuhiro Niai will officially take office after the shareholders' meeting in March next year. This is Suntory's re-election as president by members of the founder's family after about 10 years.Xia Yiping, CEO of Extreme Vietnam: The company has not closed down, and the after-sales of the whole vehicle will not be interrupted. Shareholders will bear the compensation for employees' resignation. Xia Yiping, CEO of Extreme Vietnam, said in an internal meeting that the company account has been frozen at present, and he is not the first responsible person of the enterprise, but he will try his best to solve the social security problem of employees in Beijing before 1 am tomorrow, and the social security payment problem of employees in Shanghai will be solved before the 27th. The specific operation needs to be discussed with the board of directors. Shareholders are willing to bear the compensation for employees' resignation, but the specific plan needs to be discussed with shareholders and HR department. I am still actively seeking financing. The company has not shut down or closed down, and the warranty and software services of the whole vehicle will not be interrupted.Hebang Bio established a mining engineering company in Leshan, Sichuan. The enterprise search APP shows that Leshan Hebang Mining Engineering Co., Ltd. was established recently, with Fei Wang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: mineral resources reserve evaluation service; Mineral resources reserve estimation and report preparation services; Geological disaster management services, etc. Enterprise investigation shows that the company is wholly owned by Hebang Bio.
US natural gas futures rose 6% in the day, and US natural gas futures rose 6% in the day, and are now reported at $3.353 per million British heat.Shinhiro Niai, a member of Suntory's founder family, will be the president, and Sina Gangshi will be the chairman. On December 12, it was announced that Suntory Holdings had finalized the personnel transfer, and Shinhiro Niai, a vice president from the founder family, will be promoted to the president, and the current president Sina Gangshi will be the chairman. It is expected that Nobuhiro Niai will officially take office after the shareholders' meeting in March next year. This is Suntory's re-election as president by members of the founder's family after about 10 years.Zelensky's office stated that it was ready to negotiate with Russia. Mikhail Podolyak, adviser to the director of Ukrainian President Zelensky's office, said in an interview with Channel 24 that Kiev was ready to negotiate with Russia. He pointed out that simple solutions should not be expected, and Ukraine needs just peace conditions. Earlier, Kremlin spokesman dmitry Peskov said that Russia was willing to negotiate with Ukraine provided that the conditions proposed by Russian President Vladimir Putin were met. The conditions mentioned include the complete withdrawal of Ukrainian troops from new Russian regions and Ukraine's neutrality.
In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for the replacement of generic drugs. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)Shanghai Science and Technology Commission: Increase financial support for projects in the fields of scientific instruments, scientific research reagents and technical standards in the Action Plan for Scientific and Technological Innovation, and Shanghai Science and Technology Commission issued the Action Plan for Promoting the Innovative Development of Scientific Instruments and Scientific Research Reagents in Shanghai (2025-2027). The plan points out that financial input should be increased. We will increase support for projects in the fields of scientific instruments, scientific research reagents and technical standards in the Action Plan for Science and Technology Innovation, support technology research and development, product development and standard development, select and fund high-end scientific instruments and scientific research reagent products, and support the construction of technical test and verification platforms, application scenarios and user experience centers. 16. Strengthen financial support. Establish and improve the industrial venture capital mechanism, encourage and guide market capital to participate in industrial development. Give play to the role of the parent fund of the three leading industries and the future industrial fund, encourage social capital investment, support debt financing, mergers and acquisitions, and promote enterprises to become bigger and stronger.Huaxin Securities: China Unicom's operating income grew steadily and maintained its "buy" rating. Huaxin Securities Research Report pointed out that since the beginning of this year, China Unicom (600050.SH) has seen steady growth in operating income, rapid improvement in profitability, steady expansion of user scale and continuous consolidation of network foundation, laying a more solid foundation for high-quality development of enterprises. Communication and digital intelligence services are driven by two wheels, injecting vitality into the company's performance. Looking forward to the whole year, the company will adhere to the general tone of steady progress, promote the network to be new, technology to be new and service to be new, strive to achieve the performance goal of steady growth of operating income and double-digit growth of profits throughout the year, take greater steps in high-quality development, and accelerate the construction of a world-class science and technology service enterprise with global competitiveness. With the gradual expansion of user scale and the drive of digital transformation, the company will benefit from the continuous improvement of revenue and profit and maintain the "buy" investment rating.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
Strategy guide
Strategy guide
12-13